标题
Range of adiposity and cardiorenal syndrome
作者
关键词
-
出版物
World Journal of Diabetes
Volume 11, Issue 8, Pages 322-350
出版商
Baishideng Publishing Group Inc.
发表日期
2020-08-13
DOI
10.4239/wjd.v11.i8.322
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- SGLT2 Inhibitors Produce Cardiorenal Benefits by Promoting Adaptive Cellular Reprogramming to Induce a State of Fasting Mimicry: A Paradigm Shift in Understanding Their Mechanism of Action
- (2020) Milton Packer DIABETES CARE
- Metabolically Healthy Obesity
- (2020) Matthias Blüher ENDOCRINE REVIEWS
- Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study
- (2020) Yun Kyung Cho et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction
- (2020) Jordana B. Cohen et al. JACC-Heart Failure
- Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials
- (2019) Chris J. Kapelios et al. HEART FAILURE REVIEWS
- Obesity and heart failure with preserved ejection fraction: a paradox or something else?
- (2019) Marijana Tadic et al. HEART FAILURE REVIEWS
- GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism
- (2019) M.H. Schernthaner-Reiter et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium
- (2019) Alex R Chang et al. BMJ-British Medical Journal
- Efficacy and Safety of Spironolactone in Patients With HFpEF and Chronic Kidney Disease
- (2019) Iris E. Beldhuis et al. JACC-Heart Failure
- Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Co-Transporter 2 Inhibitors for Prevention of MajorAdverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials
- (2019) Thomas A. Zelniker et al. CIRCULATION
- Non-alcoholic fatty liver disease presence and severity are associated with aortic stiffness beyond abdominal obesity: The ELSA-Brasil
- (2019) Paulo H. Harada et al. ATHEROSCLEROSIS
- Obesity, kidney dysfunction and hypertension: mechanistic links
- (2019) John E. Hall et al. Nature Reviews Nephrology
- Five-Year Outcomes of Gastric Bypass in Adolescents as Compared with Adults
- (2019) Thomas H. Inge et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk
- (2019) Todd R. Sponholtz et al. Journal of the American Heart Association
- Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry
- (2019) Sara Hallström et al. DIABETES CARE
- Changes in Left Ventricular Mass and Geometry in the Older Adults: Role of Body Mass and Central Obesity
- (2019) Tetz C. Lee et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2019) Mansoor Husain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis
- (2019) Rajiv Mahajan et al. HEART
- Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics
- (2019) Speranza Rubattu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial
- (2019) Rajiv Agarwal et al. LANCET
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF
- (2019) John J. V. McMurray et al. CIRCULATION
- Efficacy and safety of mineralocorticoid receptor antagonists with ACEI/ARB treatment for diabetic nephropathy: A meta‐analysis
- (2019) Chao Zuo et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction
- (2019) Yogesh N.V. Reddy et al. JOURNAL OF CARDIAC FAILURE
- Optimizing The Management of Obese HFpEF Phenotype: Can We Mind Both The Heart and The Kidney?
- (2019) Bharathi Upadhya et al. JOURNAL OF CARDIAC FAILURE
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
- (2019) Erik J.M. van Bommel et al. KIDNEY INTERNATIONAL
- Cardiometabolic risk factors and Framingham Risk Score in severely obese patients: Baseline data from DieTBra trial
- (2019) Annelisa S.A.C. Santos et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2019) Søren L Kristensen et al. Lancet Diabetes & Endocrinology
- Differential Regulation of ANP and BNP in Acute Decompensated Heart Failure: Deficiency of ANP
- (2019) Shawn H. Reginauld et al. JACC-Heart Failure
- Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial
- (2019) Hiddo J L Heerspink et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Cardiorenal Syndrome in Heart Failure
- (2019) Maria Rosa Costanzo Heart Failure Clinics
- Leptin, cardiovascular diseases and type 2 diabetes mellitus
- (2018) Niki Katsiki et al. ACTA PHARMACOLOGICA SINICA
- Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study
- (2018) Jane J. Lee et al. AMERICAN JOURNAL OF MEDICINE
- Cellular mechanisms underlying obesity-induced arterial stiffness
- (2018) Annayya R. Aroor et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Cardiovascular and Metabolic Heterogeneity of Obesity
- (2018) Ian J. Neeland et al. CIRCULATION
- Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench
- (2018) Neda Naderi et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis
- (2018) Luca Liberale et al. VASCULAR PHARMACOLOGY
- The pharmacological management of metabolic syndrome
- (2018) Julie Rask Larsen et al. Expert Review of Clinical Pharmacology
- Elevated GlycA in severe obesity is normalized by bariatric surgery
- (2018) Arun Manmadhan et al. DIABETES OBESITY & METABOLISM
- Circulating leptin levels predict the decline in renal function with age in a sample of adult men (The Olivetti Heart Study)
- (2018) Lanfranco D’Elia et al. Internal and Emergency Medicine
- 24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity
- (2018) Ilaria Figliuzzi et al. JOURNAL OF HUMAN HYPERTENSION
- Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories
- (2018) Kyle J Foreman et al. LANCET
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
- (2018) Adrian F Hernandez et al. LANCET
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Resistive Index Predicts Post–Bariatric Surgery Renal Outcome in Nondiabetic Individuals with Severe Obesity
- (2018) Anna Solini et al. Obesity
- Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial
- (2018) Ambarish Pandey et al. Journal of the American Heart Association
- Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis
- (2017) Camille Lassale et al. EUROPEAN HEART JOURNAL
- The effects of short-term omission of daily medication on the pathophysiology of heart failure
- (2017) Silviu Dovancescu et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity. Insight from the EMPHASIS-HF trial
- (2017) Arnaud Olivier et al. EUROPEAN JOURNAL OF HEART FAILURE
- Acutely decompensated heart failure with preserved and reduced ejection fraction present with comparable haemodynamic congestion
- (2017) Lucas N.L. Van Aelst et al. EUROPEAN JOURNAL OF HEART FAILURE
- Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Protects Against Acute Kidney Injury–Mediated Chronic Kidney DiseaseNovelty and Significance
- (2017) Lionel Lattenist et al. HYPERTENSION
- What have human experimental overfeeding studies taught us about adipose tissue expansion and susceptibility to obesity and metabolic complications?
- (2017) D J Cuthbertson et al. INTERNATIONAL JOURNAL OF OBESITY
- A causal role for hyperinsulinemia in obesity
- (2017) Nicole M Templeman et al. JOURNAL OF ENDOCRINOLOGY
- Abdominal Obesity Is Associated With an Increased Risk of All-Cause Mortality in Patients With HFpEF
- (2017) Tetsuro Tsujimoto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Metabolically Healthy Obese and Incident Cardiovascular Disease Events Among 3.5 Million Men and Women
- (2017) Rishi Caleyachetty et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Kidney outcomes three years after bariatric surgery in severely obese adolescents
- (2017) Edward J. Nehus et al. KIDNEY INTERNATIONAL
- The Renin Angiotensin Aldosterone System in Obesity and Hypertension
- (2017) Peminda K. Cabandugama et al. MEDICAL CLINICS OF NORTH AMERICA
- Epidemiology of heart failure with preserved ejection fraction
- (2017) Shannon M. Dunlay et al. Nature Reviews Cardiology
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence of Chronic Kidney Disease in Morbidly Obese Japanese and the Impact of Bariatric Surgery on Disease Progression
- (2017) Kotaro Wakamatsu et al. OBESITY SURGERY
- Bariatric Surgery can Reduce Albuminuria in Patients with Severe Obesity and Normal Kidney Function by Reducing Systemic Inflammation
- (2017) Samel Park et al. OBESITY SURGERY
- Effect of large weight reductions on measured and estimated kidney function
- (2017) Bernt Johan von Scholten et al. BMC Nephrology
- The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5
- (2017) Anna Clementi et al. CardioRenal Medicine
- Obesity
- (2017) Pedro González-Muniesa et al. Nature Reviews Disease Primers
- Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men
- (2016) M. H. A. Muskiet et al. DIABETES OBESITY & METABOLISM
- Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
- (2016) Lennart Tonneijck et al. DIABETOLOGIA
- A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease
- (2016) Gerasimos Filippatos et al. EUROPEAN HEART JOURNAL
- Severity of obesity and cardiometabolic risk factors in adults: Sex differences and role of physical activity. The HERMEX study
- (2016) Alberto Soriano-Maldonado et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction
- (2016) Kenneth B. Margulies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial
- (2016) Meredith A. Brisco et al. JOURNAL OF CARDIAC FAILURE
- Failure and Fatness
- (2016) Amanda R. Vest et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation
- (2016) Yuichi J. Shimada et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- G Protein–Coupled Receptor-G–Proteinβγ–Subunit Signaling Mediates Renal Dysfunction and Fibrosis in Heart Failure
- (2016) Fadia A. Kamal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku
- (2016) Piotr Ponikowski et al. Kardiologia Polska
- Bariatric surgery is associated with improvement in kidney outcomes
- (2016) Alex R. Chang et al. KIDNEY INTERNATIONAL
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Function and Remission of Hypertension After Bariatric Surgery: a 5-Year Prospective Cohort Study
- (2016) Karl J. Neff et al. OBESITY SURGERY
- Usefulness of Measuring Both Body Mass Index and Waist Circumference for the Estimation of Visceral Adiposity and Related Cardiometabolic Risk Profile (from the INSPIRE ME IAA Study)
- (2015) Julie-Anne Nazare et al. AMERICAN JOURNAL OF CARDIOLOGY
- Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
- (2015) J. E. Hall et al. CIRCULATION RESEARCH
- The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
- (2015) M. Volpe et al. CLINICAL SCIENCE
- Comparison of risk factors for acute worsening renal function in heart failure patients with and without preserved ejection fraction
- (2015) Tamiharu Yamagishi et al. European Journal of Internal Medicine
- Fabry’s disease: an example of cardiorenal syndrome type 5
- (2015) Aashish Sharma et al. HEART FAILURE REVIEWS
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
- (2015) George L. Bakris et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Diuretic response in acute heart failure—pathophysiology, evaluation and therapy
- (2015) Jozine M. ter Maaten et al. Nature Reviews Cardiology
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy
- (2015) Assumpta Serra et al. Obesity Facts
- Bariatric surgery in patients with reduced kidney function: an analysis of short-term outcomes
- (2015) Fady Saleh et al. Surgery for Obesity and Related Diseases
- The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
- (2015) Laurent Calvier et al. JACC-Heart Failure
- Overnutrition, mTOR signaling, and cardiovascular diseases
- (2014) Guanghong Jia et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome-an analysis from RELAX-AHF
- (2014) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Features of Cardiac Remodeling, Associated With Blood Pressure and Fibrosis Biomarkers, Are Frequent in Subjects With Abdominal Obesity
- (2014) Romain Eschalier et al. HYPERTENSION
- Bariatric surgery and its impact on cardiovascular disease and mortality: A systematic review and meta-analysis
- (2014) Chun Shing Kwok et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Relationship of Body Mass and Fat Distribution With Incident Hypertension
- (2014) Alvin Chandra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Basic science
- (2014) Adam Whaley-Connell et al. Journal of the American Society of Hypertension
- Nitric oxide synthases, S-nitrosylation and cardiovascular health: From molecular mechanisms to therapeutic opportunities (Review)
- (2014) ADRIANA V. TREUER et al. Molecular Medicine Reports
- Spironolactone for Heart Failure with Preserved Ejection Fraction
- (2014) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
- (2014) Patrick Mathieu et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- Trends in the Prevalence of Reduced GFR in the United States: A Comparison of Creatinine- and Cystatin C−Based Estimates
- (2013) Morgan E. Grams et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Pathogenesis of Chronic Cardiorenal Syndrome: Is There a Role for Oxidative Stress?
- (2013) Speranza Rubattu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data
- (2013) R Padwal et al. INTERNATIONAL JOURNAL OF OBESITY
- Risk of Myocardial Infarction and Heart Failure Among Metabolically Healthy But Obese Individuals
- (2013) Bjørn Mørkedal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Impact of Bariatric Surgery on Quality of Life, Functional Capacity, and Symptoms in Patients with Heart Failure
- (2013) William R. Miranda et al. OBESITY SURGERY
- Obesity and Kidney Disease: Potential Mechanisms
- (2013) Christopher Wickman et al. SEMINARS IN NEPHROLOGY
- Obesity and Heart Failure
- (2013) Giovanni Pergola et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Effect of Weight Loss After Bariatric Surgery on Left Ventricular Mass and Ventricular Repolarization in Normotensive Morbidly Obese Patients
- (2012) Rita Mukerji et al. AMERICAN JOURNAL OF CARDIOLOGY
- New Approaches to Sepsis: Molecular Diagnostics and Biomarkers
- (2012) K. Reinhart et al. CLINICAL MICROBIOLOGY REVIEWS
- Ace inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature
- (2012) Ali A. Valika et al. HEART FAILURE REVIEWS
- Prognostic Importance of Early Worsening Renal Function After Initiation of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Cardiac Dysfunction
- (2011) Jeffrey M. Testani et al. Circulation-Heart Failure
- Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome
- (2011) Paolo C. Colombo et al. HEART FAILURE REVIEWS
- Fatty Kidney, Hypertension, and Chronic Kidney Disease
- (2011) Meredith C. Foster et al. HYPERTENSION
- Diuretic Strategies in Patients with Acute Decompensated Heart Failure
- (2011) G. Michael Felker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice
- (2011) Lawrence J. Appel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Changes in the Obesity Phenotype Within Canadian Children and Adults, 1981 to 2007–2009
- (2011) Ian Janssen et al. Obesity
- Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)
- (2010) Aki Hiuge-Shimizu et al. ANNALS OF MEDICINE
- Computed tomography-based validation of abdominal adiposity measurements from ultrasonography, dual-energy X-ray absorptiometry and anthropometry
- (2010) Anna M. I. Gradmark et al. BRITISH JOURNAL OF NUTRITION
- Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
- (2010) M. C. Amato et al. DIABETES CARE
- Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention
- (2010) D Hofsø et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Proinflammatory cytokines in heart failure: double-edged swords
- (2010) Mona Hedayat et al. HEART FAILURE REVIEWS
- Renal Sinus Fat and Poor Blood Pressure Control in Middle-Aged and Elderly Individuals at Risk for Cardiovascular Events
- (2010) Haroon L. Chughtai et al. HYPERTENSION
- Neprilysin, obesity and the metabolic syndrome
- (2010) K F Standeven et al. INTERNATIONAL JOURNAL OF OBESITY
- The Metabolic Syndrome and Cardiovascular Risk
- (2010) Salvatore Mottillo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Acute heart failure in the intensive care unit: Epidemiology
- (2009) Owais Dar et al. CRITICAL CARE MEDICINE
- Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension
- (2009) Fabio de Souza et al. HYPERTENSION
- Obesity-Related Cardiorenal Syndrome
- (2009) Ryan Nelson et al. Journal of Clinical Hypertension
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
- (2009) Wilfried Mullens et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of Bariatric Surgery in Morbidly Obese Patients with Severe Systolic Heart Failure
- (2008) Gautam V. Ramani et al. CLINICAL CARDIOLOGY
- Increased muscle sympathetic nerve activity predicts mortality in heart failure patients
- (2008) Antonio C.P. Barretto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cardiorenal Interactions
- (2008) Anju Nohria et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Sympathetic Activation in Chronic Renal Failure
- (2008) M. P. Schlaich et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started